Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.
Georgia Tech engineers and Emory University clinicians have successfully engrafted insulin-producing cells into a diabetic mouse model, reversing diabetic symptoms in the animal in as little as 10 days.
The research team engineered a biomaterial to protect the cluster of insulin-producing cells – donor pancreatic islets – during injection. The material also contains proteins to foster blood vessel formation that allow the cells to successfully graft, survive and function within the body.
“It’s very promising,” said Andrés Garcia, Georgia Tech professor of mechanical engineering. “There is a lot of excitement because not only can we get the islets to survive and function, but we can also cure diabetes with fewer islets than are normally needed.”
The research article – a partnership with Emory’s Dr. Robert Taylor and Dr. Peter Thule that was funded in part by theJDRF, the leading global organization funding Type 1 diabetes research – will be published in the June issue of the journal Biomaterials.
Organizations such as JDRF are dedicated to finding a cure for Type 1 diabetes, a chronic disease that occurs when the pancreas produces little or no insulin, a hormone that allows the transport of sugar and other nutrients into tissues where they are converted to energy needed for daily life.
Pancreatic islet transplantation re-emerged as a promising therapy in the late 1990s. Patients with diabetes typically find it difficult to comply with multiple daily insulin injections, which only partially improve long-term outcomes. Successful islet transplantation would remove the need for patients to administer insulin. While islet transplantation trials have had some success, and control of glucose levels is often improved, diabetic symptoms have returned in most patients and they have had to revert to using some insulin.
Unsuccessful transplants can be attributed to several factors, researchers say. The current technique of injecting islets directly into the blood vessels in the liver causes approximately half of the cells to die due to exposure to blood clotting reactions. Also, the islets – metabolically active cells that require significant blood flow – have problems hooking up to blood vessels once in the body and die off over time.
Georgia Tech and Emory researchers engineered a hydrogel, a material compatible with biological tissues that is a promising therapeutic delivery vehicle. This water-swollen, cross-linked polymer surrounds the insulin-producing cells and protects them during injection. The hydrogel containing the islets was delivered to a new injection site on the outside of the small intestine, thus avoiding direct injection into the blood stream.
Once in the body, the hydrogel degrades in a controlled fashion to release a growth factor protein that promotes blood vessel formation and connection of the transplanted islets to these new vessels. In the study, the blood vessels effectively grew into the biomaterial and successfully connected to the insulin-producing cells.
Four weeks after the transplantation, diabetic mice treated with the hydrogel had normal glucose levels, and the delivered islets were alive and vascularized to the same extent as islets in a healthy mouse pancreas. The technique also required fewer islets than previous transplantation attempts, which may allow doctors to treat more patients with limited donor samples. Currently, donor cells from two to three cadavers are needed for one patient.
While the new biomaterial and injection technique is promising, the study used genetically identical mice and therefore did not address immune rejection issues common to human applications. The research team has funding from JDRF to study whether an immune barrier they created will allow the cells to be accepted in genetically different mice models. If successful, the trials could move to larger animals.
“We broke up our strategy into two steps,” said Garcia, a member of Georgia Tech’s Petit Institute for Bioengineering and Bioscience. “We have shown that when delivered in the material we engineered, the islets will survive and graft. Now we must address immune acceptance issues.”
The Latest Bing News on:
Diabetes mellitus type 1
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellituson September 20, 2023 at 5:00 pm
Type 1 diabetes mellitus is a chronic autoimmune disease caused by the pathogenic action of T lymphocytes on insulin-producing beta cells. Previous clinical studies have shown that continuous ...
- Study adds to growing evidence of link between COVID-19 and type 1 diabetes in childrenon September 15, 2023 at 7:22 pm
The children in the study who developed SARS-CoV-2 antibodies had a risk of developing multiple islet autoantibodies that was a staggering 3.5 times higher than children who did not.
- Diabetes Mellitus Type 1 Newson September 8, 2023 at 5:00 pm
Maternal Type 1 Diabetes Drives Congenital Heart Defects Review of more than 600,000 Finnish live births from 2006 to 2016 showed that mothers with type 1 diabetes had a nearly fourfold higher ...
- Type 1 Diabeteson September 8, 2023 at 5:00 pm
Reviews in Obstetrics and Gynecology: “Type 1 Diabetes Mellitus and Pregnancy.” National Diabetes Information Clearinghouse: “Your Guide to Diabetes: Type 1 and Type 2,” “Prevent ...
- What Is Diabetes Mellitus?on September 7, 2023 at 6:52 am
Diabetes mellitus—more commonly known as diabetes ... These types include: Type 1 diabetes (T1D): About 5% to 10% of people with diabetes have this form. Historically, people sometimes called ...
- What Is Diabetes Mellitus?on September 6, 2023 at 2:00 pm
Medically reviewed by Anju Goel, MD, MPH Diabetes mellitus—more commonly known as diabetes—is a chronic disease that occurs when you have higher than normal levels of blood glucose (or, blood sugar).
- Diabetes Mellitus Treatment Market Analysis Report 2023-2030 | 106 Pages Reporton September 4, 2023 at 8:10 pm
1.2 Classification of Diabetes Mellitus Treatment by Type 1.2.1 Overview: Global Diabetes Mellitus Treatment Market Size by Type: 2017 Versus 2021 Versus 2030 1.2.2 Global Diabetes Mellitus ...
- Current Management of Glycemia in Children with Type 1 Diabetes Mellituson July 8, 2023 at 7:29 am
There is no family history of type 1 diabetes mellitus; her mother has hypothyroidism, and a younger brother is well. On examination, her weight is 40 kg (32nd percentile), height 150 cm (27th ...
- Blockade of interleukin 1 in type 1 diabetes mellituson May 1, 2023 at 2:46 pm
Interleukin 1 (IL-1) is a 17 kDa protein highly conserved through evolution and is a key mediator of inflammation, fever and the acute-phase response. IL-1 has important functions in the innate ...
- Musculoskeletal manifestations of diabetes mellituson January 30, 2023 at 8:50 pm
1 Most of these patients (85%) have type 2 diabetes mellitus. Type 1 generally starts in the young as an autoimmune mediated disease of pancreatic dysfunction, and requires lifelong parenteral insulin ...
The Latest Google Headlines on:
Diabetes mellitus type 1
[google_news title=”” keyword=”Diabetes mellitus type 1″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cure for type 1 diabetes
- Children with Type-1 diabetes: DIET organises training for teacherson September 24, 2023 at 9:09 pm
Kozhikode is conducting a special training programme for teachers working in schools which have Type-1 diabetic students. This is a first for the state and teachers are being provided ...
- Experts say diabetes can be reversed. Navigating the path to diabetes treatment with Ayurvedaon September 24, 2023 at 7:29 pm
"Because type 2 diabetes is a chronic disease, we don't say 'cured.' "We call it remission instead," says Ayurveda Endocrinology Specialist Dr. Soumya Hullannavar "Once your diabetes is in remission, ...
- JDRF One Walk in Portland helps raise money for Type 1 Diabeteson September 24, 2023 at 1:05 pm
The annual JDRF One Walk was held at Payson Park in Portland Saturday in order to raise money for Type 1 Diabetes research. More than 30 teams and hundreds of walkers took part to raise more than ...
- What Is Type 1 Diabetes?on September 22, 2023 at 4:59 am
Type 1 diabetes is an autoimmune condition in which the body mistakenly attacks the insulin-producing cells in the pancreas. This leads to little to no insulin in the body and causes high blood sugar ...
- Type 1 vs. Type 2 Diabetes: Different Insulin Effectson September 20, 2023 at 2:52 pm
Type 1 diabetes is an autoimmune condition in which the immune system attacks and destroys the insulin-producing cells in the pancreas. Type 2 diabetes is a chronic condition that develops slowly over ...
- Uniink: A new 3D bioprinted cell therapy approach for Type 1 diabeteson September 18, 2023 at 8:09 pm
Javier Ramón Azcón, an ICREA research professor and the leader of the Biosensors for Bioengineering group at the Institute for Bioengineering of Catalonia (IBEC), has been granted an "ERC Proof of ...
- Quarter-sized implant offers promising Type 1 diabetes treatmenton September 18, 2023 at 12:43 pm
Someday, a single, battery-free implant could replace injections as a long-term treatment for Type 1 diabetes and other diseases that need multiple deliveries of therapeutic proteins.
- European funding for the treatment of Type 1 diabetes using 3D bioprintingon September 18, 2023 at 12:08 am
Ramón's project has been named "Uniink" and centers around the treatment of Type 1 diabetes using cell therapy and 3D bioprinting. Type 1 diabetes is a condition in which the immune system itself ...
- After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulinon September 8, 2023 at 12:43 am
In a small study with 10 participants, researchers report that semaglutides, which are sold under brand names such as Ozempic and Wegovy, shows promise as a treatment for type 1 diabetes that doesn't ...
- After treatment with semaglutide, newly diagnosed type 1 diabetes patients found to need little or no insulinon September 6, 2023 at 2:02 pm
Treating newly diagnosed type 1 diabetes patients with semaglutide ... the goal of the current study was to see if semaglutide treatment could be used to replace mealtime insulin, thereby reducing ...
The Latest Google Headlines on:
Cure for type 1 diabetes
[google_news title=”” keyword=”cure for type 1 diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]